title: Systemic treatment for alopecia areata.
abstract: Of the world population, 1.7% is suffering from alopecia areata at some point in their lives. The exact etiology of this disease is still unknown, and the course of the disease is unpredictable. Effective treatments, especially for severe multifocal alopecia areata, alopecia areata totalis, and alopecia areata universalis, are lacking. The present article will discuss side effects and relapse rates of different systemic agents for treatment of severe and rapid progressive alopecia areata.
authors.affiliation: Skin and Laser Center Potsdam, Hair Clinic, Potsdam, Germany. ninaotberg@gmx.com
authors.forename: Nina
authors.initials: N
authors.lastname: Otberg
mesh_terms: D000328:Adult; D000506:Alopecia Areata / Q000188:drug therapy* / Q000473:pathology; D000818:Animals; D018450:Disease Progression; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012720:Severity of Illness Index
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents